| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4288269
[patent_doc_number] => 06197294
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-06
[patent_title] => 'Cell surface molecule-induced macrophage activation'
[patent_app_type] => 1
[patent_app_number] => 9/178869
[patent_app_country] => US
[patent_app_date] => 1998-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12667
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/197/06197294.pdf
[firstpage_image] =>[orig_patent_app_number] => 178869
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/178869 | Cell surface molecule-induced macrophage activation | Oct 25, 1998 | Issued |
Array
(
[id] => 1504112
[patent_doc_number] => 06465438
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-15
[patent_title] => 'Nucleic acid vaccination for parvoviral infections'
[patent_app_type] => B1
[patent_app_number] => 09/171425
[patent_app_country] => US
[patent_app_date] => 1998-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5905
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/465/06465438.pdf
[firstpage_image] =>[orig_patent_app_number] => 09171425
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/171425 | Nucleic acid vaccination for parvoviral infections | Oct 18, 1998 | Issued |
| 09/173947 | GENE DELIVERY VECTORS AND THEIR USES | Oct 15, 1998 | Abandoned |
| 09/168883 | TREATMENT OF NEOPLASMS WITH VIRUSES | Oct 8, 1998 | Abandoned |
Array
(
[id] => 1208300
[patent_doc_number] => 06713054
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Cellular immunotherapy treatment of patients afflicted with chronic fatigue syndrome'
[patent_app_type] => B1
[patent_app_number] => 09/167764
[patent_app_country] => US
[patent_app_date] => 1998-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 6254
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713054.pdf
[firstpage_image] =>[orig_patent_app_number] => 09167764
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/167764 | Cellular immunotherapy treatment of patients afflicted with chronic fatigue syndrome | Oct 6, 1998 | Issued |
Array
(
[id] => 1399672
[patent_doc_number] => 06541616
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Moraxella catarrhalis protein, gene sequence and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/164714
[patent_app_country] => US
[patent_app_date] => 1998-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20743
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541616.pdf
[firstpage_image] =>[orig_patent_app_number] => 09164714
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/164714 | Moraxella catarrhalis protein, gene sequence and uses thereof | Sep 30, 1998 | Issued |
| 09/161659 | METHOD OF INDUCING DIFFERENTIATION OF NORMAL AND CANCER CELLS | Sep 28, 1998 | Abandoned |
Array
(
[id] => 1073616
[patent_doc_number] => 06838281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Cells expressing fusion proteins of immunoglobulins'
[patent_app_type] => utility
[patent_app_number] => 09/160076
[patent_app_country] => US
[patent_app_date] => 1998-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12393
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838281.pdf
[firstpage_image] =>[orig_patent_app_number] => 09160076
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/160076 | Cells expressing fusion proteins of immunoglobulins | Sep 23, 1998 | Issued |
Array
(
[id] => 4173522
[patent_doc_number] => 06140476
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Rep-max protein having anti-oncogenic activity and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/158477
[patent_app_country] => US
[patent_app_date] => 1998-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 7343
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140476.pdf
[firstpage_image] =>[orig_patent_app_number] => 158477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/158477 | Rep-max protein having anti-oncogenic activity and uses thereof | Sep 21, 1998 | Issued |
| 09/156314 | TRANSGENIC AUTOLOGOUS T-CELL THERAPY IN HUMANS, AND RELATED COMPOSITONS AND KITS | Sep 16, 1998 | Abandoned |
Array
(
[id] => 4359034
[patent_doc_number] => 06218594
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'Guinea pig model for leiomyomas'
[patent_app_type] => 1
[patent_app_number] => 9/068365
[patent_app_country] => US
[patent_app_date] => 1998-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 8
[patent_no_of_words] => 12148
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218594.pdf
[firstpage_image] =>[orig_patent_app_number] => 068365
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/068365 | Guinea pig model for leiomyomas | Sep 15, 1998 | Issued |
Array
(
[id] => 1514381
[patent_doc_number] => 06420176
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-16
[patent_title] => 'Composition for delivering DNA into antigen presenting cells'
[patent_app_type] => B1
[patent_app_number] => 09/153198
[patent_app_country] => US
[patent_app_date] => 1998-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9663
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/420/06420176.pdf
[firstpage_image] =>[orig_patent_app_number] => 09153198
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/153198 | Composition for delivering DNA into antigen presenting cells | Sep 14, 1998 | Issued |
| 09/138928 | CELL POPULATION CONTAINING NON-FETAL HEMANGIOBLASTS AND METHOD FOR PRODUCING SAME | Aug 23, 1998 | Abandoned |
Array
(
[id] => 4134927
[patent_doc_number] => 06147202
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-14
[patent_title] => 'Production of human hemoglobin in transgenic pigs'
[patent_app_type] => 1
[patent_app_number] => 9/138922
[patent_app_country] => US
[patent_app_date] => 1998-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 78
[patent_no_of_words] => 17641
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/147/06147202.pdf
[firstpage_image] =>[orig_patent_app_number] => 138922
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/138922 | Production of human hemoglobin in transgenic pigs | Aug 23, 1998 | Issued |
Array
(
[id] => 4285144
[patent_doc_number] => 06210964
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-03
[patent_title] => 'Avian extracellular calcium-sensing receptor'
[patent_app_type] => 1
[patent_app_number] => 9/134513
[patent_app_country] => US
[patent_app_date] => 1998-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 32
[patent_no_of_words] => 13414
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/210/06210964.pdf
[firstpage_image] =>[orig_patent_app_number] => 134513
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/134513 | Avian extracellular calcium-sensing receptor | Aug 13, 1998 | Issued |
| 09/130367 | METHOD OF CONTROLLING PROLIFERATION AND DIFFERENTIATION OF STEM AND PROGENITOR CELLS | Aug 6, 1998 | Abandoned |
Array
(
[id] => 6670637
[patent_doc_number] => 20030115622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'PRODUCTION OF AVIAN EMBRYONIC GERM (EG) CELL LINES BY PROLONGED CULTURING OF PGC\'S, USE THEREOF FOR CLONING AND CHIMERIZATION'
[patent_app_type] => new
[patent_app_number] => 09/127738
[patent_app_country] => US
[patent_app_date] => 1998-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9643
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20030115622.pdf
[firstpage_image] =>[orig_patent_app_number] => 09127738
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/127738 | PRODUCTION OF AVIAN EMBRYONIC GERM (EG) CELL LINES BY PROLONGED CULTURING OF PGC'S, USE THEREOF FOR CLONING AND CHIMERIZATION | Aug 2, 1998 | Abandoned |
| 09/127624 | PROLONGED CULTURING OF AVIAN (CHICKEN) PRIMORDIAL GERM CELLS (PGCS) USING SPECIFIC GROWTH FACTORS USE THEREOF TO PRODUCE CHIMERIC AVIANS (CHICKENS) | Aug 2, 1998 | Abandoned |
Array
(
[id] => 3979778
[patent_doc_number] => 05948768
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-07
[patent_title] => 'Treatment of otitis media by sublingual administration of DNA'
[patent_app_type] => 1
[patent_app_number] => 9/123800
[patent_app_country] => US
[patent_app_date] => 1998-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3696
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/948/05948768.pdf
[firstpage_image] =>[orig_patent_app_number] => 123800
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/123800 | Treatment of otitis media by sublingual administration of DNA | Jul 27, 1998 | Issued |
Array
(
[id] => 6934729
[patent_doc_number] => 20010056073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-27
[patent_title] => 'GENE THERAPY METHOD FOR REVASCULARIZING ISCHEMIC TISSUE'
[patent_app_type] => new
[patent_app_number] => 09/120493
[patent_app_country] => US
[patent_app_date] => 1998-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5450
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0056/20010056073.pdf
[firstpage_image] =>[orig_patent_app_number] => 09120493
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/120493 | GENE THERAPY METHOD FOR REVASCULARIZING ISCHEMIC TISSUE | Jul 20, 1998 | Abandoned |